Skip to main content
ADCES26 Main banner
Visit TZIELD at Booth #1510 (Sanofi Ad)

On-Demand

Cardiometabolic Conditions and Treatment Options

(CS01) Practical Applications for Prandial Insulin: The Gateway to Diabetes Health

Saturday, August 8, 2026
10:40 AM - 11:25 AM ET
CE: .75 CE
Pharmacology Hours: .75 CE
Post-prandial hyperglycemia is an independent predictor of cardiovascular disease and significantly increases the risks of diabetes-related complications. Prandial insulin therapies are often underutilized in diabetes management, and optimizing use of prandial insulin can be a challenge. A comprehensive understanding of the diverse prandial insulin landscape can help optimize glycemic management and individualize diabetes care.
This session will explore the role of prandial insulin as the “gateway” to improve diabetes health. Emphasis will be placed on practical strategies for initiating and titrating insulin for youth and adults with diabetes, including inhaled insulin as a patient-centered option to reduce barriers and support treatment intensification.

This session is supported by an independent educational grant from MannKind Corporation.

Learning Objectives:

At the completion of this activity, participants should be able to:
  • Identify available prandial insulins and options for delivering prandial insulin (injectable, insulin pumps and inhaled)
  • Discuss key clinical considerations for shared decision making in choosing a prandial insulin delivery method for a person with diabetes
  • Utilize practical tips for initiating and titrating prandial insulin doses to optimize diabetes management
  • Explain the differences in insulin action between inhaled and injectable prandial insulins
Disclosure(s):
Nykkia Sellers, DNP, FNP, BC-ADM, CDCES: No financial relationships to disclose